Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors

被引:35
作者
Chamberlain, Marc C. [1 ,3 ]
Born, Donald [2 ]
机构
[1] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
[2] Stanford Univ, Dept Pathol Neuropathol, Palo Alto, CA 94304 USA
[3] Univ Washington, Fred Hutchison Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98109 USA
关键词
Oligodendroglioma; Polysomy; Relative1p/19q codeletion; POLYSOMY; PREDICTS; 19Q; 1P;
D O I
10.1007/s11060-015-1906-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1p/19q codeletion is a favorable prognostic marker for oligodendroglial tumors (OT). Compare outcome in OT with simple deletions of 1p or 19q to those with relative deletions defined as the presence of both increased copy number (polysomy) and 1p/19q codeletion. 525 cases were examined by fluorescence in situ hybridization (FISH) using dual color probes to determine the deletion status of chromosome arms 1p and 19q. Categories included simple deletions defined as a proportion of either 1p32 or 19q13 FISH signals compared to 1q42 or 19p13 signals less than 0.80 and relative deletions (1p or 19q) defined as the combination of a < 0.80 proportion with > 30 % of nuclei showing increased chromosome number (based on enumeration of 1q25 or 19p13). 464 (80 %) were WHO Grade II or III OT of which 209 (48 %) had both 1p and 19q deleted (codeletion). 72 (16 %) had relative deletions for either one or both 1p and 19q of which 28 (6 %) had relative deletions of 1p and 19q (relative codeletion). Overall survival in WHO Grade II OT was 13 + years when 1p/19q codeleted (n = 156); 5 + years in uni- or nondeleted (n = 86); 6 + years in relative deletion for either 1p or 19q (n = 41); and 6 + years in relative 1p/19q codeletion (n = 15). Similarly in WHO Grade III OT (n = 168) overall survival was 11 + years in 1p/19q codeleted (n = 54) OT; 2.5 years in uni- or nondeleted (n = 70); 3 years in relative deletion for one or both 1p or 19q (n = 31); and 4 + years in relative 1p/19q codeletion (n = 13). Survival for OT regardless of grade with relative codeletion of 1p/19q was approximately one half that of 1p/19q codeleted tumors. The presence of relative 1p/19q codeletion is of prognostic significance.
引用
收藏
页码:249 / 251
页数:3
相关论文
共 12 条
[1]  
Buckner J, 2014, NEUROONCOL S5, V16
[2]   Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402 [J].
Cairncross, Gregory ;
Wang, Meihua ;
Shaw, Edward ;
Jenkins, Robert ;
Brachman, David ;
Buckner, Jan ;
Fink, Karen ;
Souhami, Luis ;
Laperriere, Normand ;
Curran, Walter ;
Mehta, Minesh .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) :337-343
[3]   Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas [J].
Cairncross, JG ;
Ueki, K ;
Zlatescu, MC ;
Lisle, DK ;
Finkelstein, DM ;
Hammond, RR ;
Silver, JS ;
Stark, PC ;
Macdonald, DR ;
Ino, Y ;
Ramsay, DA ;
Louis, DN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) :1473-1479
[4]   Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas [J].
Fallon, KB ;
Palmer, CA ;
Roth, KA ;
Nabors, LB ;
Wang, W ;
Carpenter, M ;
Banerjee, R ;
Forsyth, P ;
Rich, K ;
Perry, A .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (04) :314-322
[5]   A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma [J].
Jenkins, Robert B. ;
Blair, Hilary ;
Ballman, Karla V. ;
Giannini, Caterina ;
Arusell, Robert M. ;
Law, Mark ;
Flynn, Heather ;
Passe, Sandra ;
Felten, Sara ;
Brown, Paul D. ;
Shaw, Edward G. ;
Buckner, Jan C. .
CANCER RESEARCH, 2006, 66 (20) :9852-9861
[6]   Polysomy of chromosomes 1 and 19: an underestimated prognostic factor in oligodendroglial tumors [J].
Jiang, Haihui ;
Ren, Xiaohui ;
Zhang, Zhe ;
Zeng, Wei ;
Wang, Junmei ;
Lin, Song .
JOURNAL OF NEURO-ONCOLOGY, 2014, 120 (01) :131-138
[7]  
Perry A, 2007, WHO CLASSIFICATION T, P54
[8]   Co-polysomy of chromosome 1q and 19p predicts worse prognosis in 1p/19q codeleted oligodendroglial tumors: FISH analysis of 148 consecutive cases [J].
Ren, Xiaohui ;
Jiang, Haihui ;
Cui, Xiangli ;
Cui, Yong ;
Ma, Jun ;
Jiang, Zhongli ;
Sui, Dali ;
Lin, Song .
NEURO-ONCOLOGY, 2013, 15 (09) :1244-1250
[9]   Polysomy for Chromosomes 1 and 19 Predicts Earlier Recurrence in Anaplastic Oligodendrogliomas with Concurrent 1p/19q Loss [J].
Snuderl, Matija ;
Eichler, April F. ;
Ligon, Keith L. ;
Vu, Quynh U. ;
Silver, Michael ;
Betensky, Rebecca A. ;
Ligon, Azra H. ;
Wen, Patrick Y. ;
Louis, David N. ;
Iafrate, A. John .
CLINICAL CANCER RESEARCH, 2009, 15 (20) :6430-6437
[10]   Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951 [J].
van den Bent, Martin J. ;
Brandes, Alba A. ;
Taphoorn, Martin J. B. ;
Kros, Johan M. ;
Kouwenhoven, Mathilde C. M. ;
Delattre, Jean-Yves ;
Bernsen, Hans J. J. A. ;
Frenay, Marc ;
Tijssen, Cees C. ;
Grisold, Wolfgang ;
Sipos, Laszlo ;
Enting, Roelien H. ;
French, Pim J. ;
Dinjens, Winand N. M. ;
Vecht, Charles J. ;
Allgeier, Anouk ;
Lacombe, Denis ;
Gorlia, Thierry ;
Hoang-Xuan, Khe .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) :344-350